8-K: Nuvve Holding Corp. Faces Nasdaq Delisting
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
Nuvve Holding Corp. received a determination to delist its common stock from The Nasdaq Capital Market due to non-compliance with listing rules, with trading to be suspended effective July 24, 2026.
Summary
- Nuvve Holding Corp. has been notified by Nasdaq of a determination to delist its common stock.
- The delisting is due to non-compliance with several Nasdaq Listing Rules, including periodic reporting requirements (specifically the Q1 2026 Form 10-Q), the minimum bid price requirement, and the minimum stockholders' equity requirement.
- Trading of the company's common stock on Nasdaq is set to be suspended starting July 24, 2026.
- The company's securities will begin trading on the Pink Limited Information Tier of the OTC Markets under the symbol NVVE, effective July 24, 2026.
- Nuvve intends to apply for inclusion in the OTCID and subsequently the OTCQB tiers of the OTC Markets.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a significantly negative development due to the delisting from Nasdaq and the reasons cited for non-compliance.
Negatives
- The company's common stock is being delisted from The Nasdaq Capital Market.
- Failure to demonstrate compliance with Nasdaq's periodic reporting rule, specifically regarding the Q1 2026 Form 10-Q.
- Failure to meet the minimum bid price requirement of $1.00.
- Failure to meet the minimum stockholders' equity requirement of $2,500,000.
Risks
- Potential for continued non-compliance with listing requirements on OTC Markets.
- Reduced liquidity and investor visibility by trading on OTC Markets compared to Nasdaq.
- Difficulty in regaining Nasdaq listing in the future.
- Uncertainty regarding the outcome of any appeal to the Nasdaq Listing and Hearing Review Council.
Future Outlook
The company is considering all available options to reinitiate trading on Nasdaq as soon as practicable and expects its common stock to begin trading on the Pink Limited Information Tier of the OTC Markets system effective at the open of trading on Friday, July 24, 2026. The company intends to promptly apply to have its securities included in the OTCID tier and subsequently the OTCQB tier of the OTC Markets system.
Management Comments
- The Company is considering all available options to reinitiate trading on Nasdaq as soon as practicable.
- The Company expects its Common Stock to begin trading on the Pink Limited Information Tier of the OTC Markets system under its current trading symbol of NVVE effective at the open of trading on Friday, July 24, 2026.
- The Company intends to promptly apply to have its securities included in the OTCID tier and subsequently the OTCQB tier of the OTC Markets system.
Industry Context
StockSavvy.ai notes that delisting from a major exchange like Nasdaq and moving to the OTC markets often signifies significant financial distress or operational challenges, impacting investor confidence and access to capital.
Stakeholder Impact
- Shareholders will experience a significant reduction in trading liquidity and potentially a decrease in share value due to the move to OTC markets.
- Investors may face increased difficulty in accessing reliable information and trading the stock.
- Creditors and other financial stakeholders may view the delisting as a sign of financial instability.
Next Steps
- Trading of common stock to be suspended on Nasdaq effective July 24, 2026.
- Common stock to begin trading on the Pink Limited Information Tier of the OTC Markets under NVVE effective July 24, 2026.
- Company to promptly apply for inclusion in the OTCID tier and subsequently the OTCQB tier of the OTC Markets system.
- Company to consider all available options to reinitiate trading on Nasdaq.
Key Dates
| Date | Description |
|---|---|
| 2026-03-31 | Period ended for the Quarterly Report on Form 10-Q that contributed to non-compliance. |
| 2026-04-20 | Company was initially notified by Nasdaq's Listing Qualifications Department of non-compliance with the Bid Price Rule. |
| 2026-05-22 | Nasdaq notified the Company that non-compliance with the Periodic Reporting Rule could serve as an additional basis for delisting. |
| 2026-05-28 | Company presented its plan to evidence compliance with the Rules at a hearing. |
| 2026-07-09 | The Nasdaq Hearings Panel issued its decision requiring filing of the Quarterly Report and compliance with Equity Rule by July 13, 2026, and Bid Price Rule compliance by July 31, 2026. |
| 2026-07-13 | Deadline for filing the Quarterly Report and compliance with the Equity Rule as per the Panel's decision. |
| 2026-07-22 | Date of the report and the date the Company received the written Delist Determination from Nasdaq. |
| 2026-07-24 | Effective date for the suspension of trading on Nasdaq and commencement of trading on the OTC Markets Pink Limited Information Tier. |
Recommendation
sellThe delisting from Nasdaq due to multiple listing rule violations, including financial reporting and equity requirements, indicates severe operational and financial challenges. The move to the OTC markets signifies a substantial downgrade in market status and liquidity, making it a high-risk investment.
Keywords
Nasdaq Delisting, OTC Markets, Periodic Reporting, Bid Price, Stockholders Equity, Form 8-K, Nuvve Holding Corp.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.